A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

Clinical trial NCT03861403 · TERMINATED

Trial details

NCT number: NCT03861403
Sponsor: Leap Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Advanced Triple Negative Breast Cancer Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer Advanced Metastatic Castration-Resistant Prostate Cancer Advanced Platinum-Resistant Ovarian Cancer

Start date: 2019-05-20
Primary completion: 2020-07-14
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.